N/A N=26 Pre-Exposure Prophylaxis in the Emergency Department
HIV/AIDS · PrEP
Primary: Engagement in Care (Implementation Component) — 1; 1 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=177 mHealth Behavioral Cancer Pain Intervention for Medically Underserved Patients
Breast Cancer
Primary: Pain Severity as Measured by the Brief Pain Inventory (BPI) — 4.71; 4.51; 3.52; 4.69 score on a scale
Early Phase 1 N=46 Assessment of Renal Function by Multiparametric MRI
Renal Impairment
Primary: T1 Time — 1500 ms
Phase 3 N=585 A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC
Extensive Stage Small Cell Lung Cancer
Primary: OS — 15.77; 11.10 month — p=<0.001
N/A N=25 Effects of Cigarette and E-cigarette Flavors on Substitutability in the ETM
Cigarette Smoking Behavior
Primary: Nicotine/Tobacco Products Substitution — 1326.25; 206; 120.83; 46.79 mg of nicotine purchased
N/A N=215 Incidence of HANA Conditions in HIV-infected Individuals
HIV · Metabolic Syndrome · Osteopenia
Primary: Prevalences of HIV-associated Non-AIDS Conditions (HANA) — 69; 15; 30; 4 Participants — p=0.244
N/A N=43 Watchman FLX Pro CT Pilot Study
Non-valvular Atrial Fibrillation (AF)
Primary: Number of Participants With Any Hypoattenuated Thickening (HAT) on the Surface of the Device — 3; 5; 5 Participants
N/A N=1,825 Using Practice Facilitation and Operationalizing Referral Information Technology to Increase DSMES Utilization
Diabetes
Primary: Diabetes Self-Management Education and Support (DSMES) Referrals — 0; 0; 4; 343 Participants
N/A N=218 A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions.
Invasive Aspergillosis · Mucormycosis
Primary: Number of Participants With Clinical Response at Week 6 — 173; 14; 27; 3 Participants
Phase 2 N=21 Tranexamic Acid Dosing for Major Joint Replacement Surgery
Arthroplasty, Replacement, Knee · Arthroplasty, Replacement, Hip
Primary: Blood Plasma TXA Concentration - Total Body Clearance — 58.0; 116 mL/min
Phase 2 N=130 Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)
Vertigo · Dizziness
Primary: VRT vs. ED SOC Six-Category Diagnosis Accuracy (Primary Analysis-eligible Participants, Two-arm Comparison) — 24; 18; 33; 38 Participants
N/A N=120 Personalized Integrated Chronotherapy for Perinatal Depression
Depression · Postpartum Depression · Prenatal Disorder
Primary: Change in Depressive Symptoms — 1.6; 2.2 units on a scale
Phase 3 N=301 A Extension Study of Udenafil in Adolescents
Functional Single Ventricle Heart Disease
Primary: Treatment-Emergent Adverse Events — 257; 206; 31; 54 Participants
N/A N=42 Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
Breast Cancer
Primary: Overall Survival (OS) — 85.42 Months
N/A N=46 Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep South
HIV Infections · Sexually Transmitted Diseases
Primary: Feasibility of Intervention Implementation — 4.28 Scores on a scale